Wallace Pharmaceuticals

About Us

Wallace Pharmaceuticals is a leading pharmaceutical company committed to enhacing people’s lives through innovative, high-quality medicines. It is owned by the Menzes family, which has a long-standing legacy in the Indian pharmaceutical industry. They have played a significant role in the growth and development of the industry in India and have received several awards and recognitions for their contributions. 

Wallace Pharmaceuticals has a diversified product portfolio that includes medications for various therapeutic areas such as cardiology, gastroenterology, neurology, and respiratory diseases. The company also has a strong presence in the nutraceuticals and cosmeceuticals segments. In addition to manufacturing pharmaceuticals, the company also engages in contract manufacturing for several reputed international pharmaceutical companies.

Our Values

  • To conduct our business with Integrity, Honesty, and Transparency.
  • To create and maintain best-in-class standards across all areas of work.
  • To encourage mutual trust, respect, and teamwork.
  • To develop customer focused systems and practices.

Our Goal

Our goal is to be a global leader in affordable niche healthcare solutions that are available to anyone, anywhere in the world.

Our Goal


Our goal is to be a global leader in affordable niche healthcare solutions that are available to anyone, anywhere in the world.

Our Values

  • To conduct our business with Integrity, Honesty, and Transparency.
  • To create and maintain best-in-class standards across all areas of work.
  • To encourage mutual trust, respect, and teamwork.
  • To develop customer focused systems and practices.

Our Goal


Our goal is to be a global leader in affordable niche healthcare solutions that are available to anyone, anywhere in the world.

Our Values

  • To conduct our business with Integrity, Honesty, and Transparency.
  • To create and maintain best-in-class standards across all areas of work.
  • To encourage mutual trust, respect, and teamwork.
  • To develop customer focused systems and practices.

Our Story

1910

Cosme Mathais Menezes starts a pharmacy in Goa,which was a former Portugese colony in South India .

1960

Pascoal Menezes starts a new company under the name CMM (named after Cosme Mathais Menezes) and it grows to become the largest trader & 2nd largest importer of drugs in India. CMM also starts its own pharmaceutical manufacturing & branded formulations

1970

CMM becomes a high quality pharmaceutical & OTC products manufacturer in India. It business grows all over India. It also grows internationally through joint ventures & licensing agreements with multinationals such as Carter-Wallace USA, Beiersdorf, Leukoplast, Winthrop & Old Spice.

1990

The Menezes family acquires Carter Wallace USA and renames the company Wallace Pharmaceuticals.All shares brought, and JV with Carter is dissolved.

1998

Indipharma is formed as an alliance

2001

The Dharwad plant for tablets capsules and oral supplements was commissioned on 16th April 2001 as per Factories act 1948. It has a production capacity of 3 million capsules; 30 million tablets and 1.2 million oral powder sachets per month. Achieving all this through implementing of sound quality management systems

2006

Wallace Lifestyle trade division is formed The first trade division was launched to serve the needs of Rheumatology, Orthopedics and Diabetes patients in the country.

2007

Commissioned in picturesque Nalagarh at the foothills of the Himalayas. The plant manufactures Tablets, Liquids and Dry Syrups. It has a total area of 20,810 Sq.Mtrs with a production capacity of 24 million tablets

2015

Paying heed to the growing needs of in the country, 4 new divisions are launched catering to a variety of therapies including Dermatology, Gynecology, Gastro-Intestinals, Anti-Infectives and more

2017

Wallace enters the ‘Top 40 pharma companies in India’ club as per ORG IMS data.

2018

In 2018, Wallace extended its presence in the field of Gastroenterology by unveiling a specialized division, named Gastrova. It majorly caters the patient’s need in various therapeutic areas such as antacid, anti-ulcerant, pancreatic enzymes & Anti-diarrheal. Diovol is the flagship brand of Gastrova division which is an antacid-antigas formulation & available in Liquid as well as tablet dosage form. Diovol is The Longest Serving Antacid of India and has completed more than 50 years of service to doctors and patients in India. Diovol is the 3rd largest selling Antacid brand in India.

2020
Wallace Innovation Center

Wallace transformed its R&D facility in 2020 into an innovation center for driving innovation, improving processes, ensuring regulatory compliance, and maintaining its competitiveness of in the dynamic and evolving healthcare landscape.

2023

Wallace’s new, cutting-edge manufacturing facility, built in 2023, was strategically designed to meet the demands of the regulated pharmaceutical market.


Commissioned in picturesque Nalagarh at the foothills of the Himalayas. The Wallace Pharmaceuticals Pvt. Ltd, Unit-II plant manufactures External Preparations (Topical Solution, Ointment, Creams, & Gels). It has a total covered area of 12832.00 Sq. Meters with a production capacity of 68.04 million tubes per annum.

2024

Welcome to Wallace - Our New Home in the Heart of Mumbai!

Wallace moves its Mumbai office to a brand-new, prestigious office space in the bustling city of Mumbai. This move reflects our commitment to growth, innovation, and serving our stakeholders with even greater efficiency.

Our Presence

Our presence in India and beyond spans over 5 decades. As of now we are present in Africa, Latin America and Asia, we are looking to expand to Europe, North America and Oceania soon…

Our Presence

Our presence in India and beyond spans over 5 decades. As of now we are present in Africa, Latin America and Asia, we are looking to expand to Europe, North America and Oceania soon…

Scroll to Top